Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998882264> ?p ?o ?g. }
- W1998882264 endingPage "484" @default.
- W1998882264 startingPage "475" @default.
- W1998882264 abstract "Introduction: Via its antiplatelet effect, aspirin reduces the odds of an arterial thrombotic event in high-risk patients by approximately 25%. However, 10% to 20% of patients with an arterial thrombotic event who are treated with aspirin have a recurrent arterial thrombotic event during long-term follow-up. Nevertheless, the effectiveness of aspirin has been questioned by the emergence of the concept of aspirin resistance, which has been introduced as an explanation of the fact that a considerable proportion of patients treated with aspirin exhibit normal platelet function. Objectives and Methods: We systematically reviewed all available evidence till March 2008 on prevalence of aspirin resistance and its association with clinical outcome. We also collected articles showing the possible way of treatment. Conclusion: Analyzing the data of different laboratory methods aspirin resistance seems to be associated with poor clinical outcome, although currently no standardized or widely accepted definition of aspirin resistance exists. The widely used laboratory methods might not be comparable with each other; therefore, specific treatment recommendations for patients who exhibit high platelet reactivity during aspirin therapy or who have poor platelet inhibition by aspirin are not established." @default.
- W1998882264 created "2016-06-24" @default.
- W1998882264 creator A5013214539 @default.
- W1998882264 creator A5013757996 @default.
- W1998882264 creator A5051623474 @default.
- W1998882264 creator A5055209214 @default.
- W1998882264 creator A5060660547 @default.
- W1998882264 creator A5061041080 @default.
- W1998882264 creator A5069522847 @default.
- W1998882264 creator A5074511813 @default.
- W1998882264 creator A5075233010 @default.
- W1998882264 date "2008-12-01" @default.
- W1998882264 modified "2023-10-17" @default.
- W1998882264 title "Aspirin Resistance: Focus on Clinical Endpoints" @default.
- W1998882264 cites W13025780 @default.
- W1998882264 cites W1501120985 @default.
- W1998882264 cites W1575525639 @default.
- W1998882264 cites W1918341369 @default.
- W1998882264 cites W1972832497 @default.
- W1998882264 cites W1981244322 @default.
- W1998882264 cites W1981500593 @default.
- W1998882264 cites W1982508653 @default.
- W1998882264 cites W1988143463 @default.
- W1998882264 cites W1988516002 @default.
- W1998882264 cites W1999762372 @default.
- W1998882264 cites W2014904348 @default.
- W1998882264 cites W2019399894 @default.
- W1998882264 cites W2020638574 @default.
- W1998882264 cites W2024352468 @default.
- W1998882264 cites W2029363362 @default.
- W1998882264 cites W2035417874 @default.
- W1998882264 cites W2035785733 @default.
- W1998882264 cites W2036840178 @default.
- W1998882264 cites W2039881470 @default.
- W1998882264 cites W2042232724 @default.
- W1998882264 cites W2042800640 @default.
- W1998882264 cites W2051297375 @default.
- W1998882264 cites W2052247317 @default.
- W1998882264 cites W2056339290 @default.
- W1998882264 cites W2056845379 @default.
- W1998882264 cites W2059064084 @default.
- W1998882264 cites W2061689857 @default.
- W1998882264 cites W2065928940 @default.
- W1998882264 cites W2066072643 @default.
- W1998882264 cites W2071620674 @default.
- W1998882264 cites W2072386538 @default.
- W1998882264 cites W2072518791 @default.
- W1998882264 cites W2076845784 @default.
- W1998882264 cites W2079683014 @default.
- W1998882264 cites W2083061851 @default.
- W1998882264 cites W2083087786 @default.
- W1998882264 cites W2083134865 @default.
- W1998882264 cites W2088680944 @default.
- W1998882264 cites W2089858634 @default.
- W1998882264 cites W2090940723 @default.
- W1998882264 cites W2096336546 @default.
- W1998882264 cites W2103688147 @default.
- W1998882264 cites W2106710479 @default.
- W1998882264 cites W2120027412 @default.
- W1998882264 cites W2126142444 @default.
- W1998882264 cites W2135563134 @default.
- W1998882264 cites W2137392449 @default.
- W1998882264 cites W2140261980 @default.
- W1998882264 cites W2147195562 @default.
- W1998882264 cites W2147294426 @default.
- W1998882264 cites W2150912899 @default.
- W1998882264 cites W2152401347 @default.
- W1998882264 cites W2156228167 @default.
- W1998882264 cites W2156278436 @default.
- W1998882264 cites W2161043271 @default.
- W1998882264 cites W2171267144 @default.
- W1998882264 cites W4239471829 @default.
- W1998882264 cites W4240019765 @default.
- W1998882264 doi "https://doi.org/10.1097/fjc.0b013e31818eee5f" @default.
- W1998882264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19034037" @default.
- W1998882264 hasPublicationYear "2008" @default.
- W1998882264 type Work @default.
- W1998882264 sameAs 1998882264 @default.
- W1998882264 citedByCount "17" @default.
- W1998882264 countsByYear W19988822642012 @default.
- W1998882264 countsByYear W19988822642013 @default.
- W1998882264 countsByYear W19988822642014 @default.
- W1998882264 countsByYear W19988822642015 @default.
- W1998882264 countsByYear W19988822642016 @default.
- W1998882264 countsByYear W19988822642017 @default.
- W1998882264 countsByYear W19988822642018 @default.
- W1998882264 crossrefType "journal-article" @default.
- W1998882264 hasAuthorship W1998882264A5013214539 @default.
- W1998882264 hasAuthorship W1998882264A5013757996 @default.
- W1998882264 hasAuthorship W1998882264A5051623474 @default.
- W1998882264 hasAuthorship W1998882264A5055209214 @default.
- W1998882264 hasAuthorship W1998882264A5060660547 @default.
- W1998882264 hasAuthorship W1998882264A5061041080 @default.
- W1998882264 hasAuthorship W1998882264A5069522847 @default.
- W1998882264 hasAuthorship W1998882264A5074511813 @default.
- W1998882264 hasAuthorship W1998882264A5075233010 @default.
- W1998882264 hasBestOaLocation W19988822641 @default.
- W1998882264 hasConcept C126322002 @default.